SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-23-056119
Filing Date
2023-12-04
Accepted
2023-12-04 16:05:27
Documents
4
Period of Report
2023-12-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20013527x1_pre14a.htm PRE 14A 163462
2 logo_seelostherapeutics.jpg GRAPHIC 38514
3 ny20013527x1_pc01.jpg GRAPHIC 730433
4 ny20013527x1_pc02.jpg GRAPHIC 709163
  Complete submission text file 0001140361-23-056119.txt   2199567
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-22245 | Film No.: 231463009
SIC: 2834 Pharmaceutical Preparations